论文信息 - Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia - 字舞流文

Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia

F. Holz | R. Finger | H. Scholl | P. C. Issa | R. Finger | P. Issa | F. G. Holz | H P N Scholl